Professor POON Chiu Yee, Liona
Chairperson, Department of Obstetrics and Gynaecology
CUHK Employment
Chairperson, Department of Obstetrics and Gynaecology
Expertise
- Clinical maternal fetal medicine:
- Prenatal screening, diagnosis and counselling with state-of-the-art technologies, including advanced ultrasonography, non-invasive prenatal testing using maternal circulating cell-free fetal DNA (cfDNA), and next generation sequencing, such as whole exome sequencing
- Fetal therapy including fetoscopic laser therapy for twin-twin transfusion syndrome, radiofrequency ablation of umbilical vessels for selective fetal reduction, in-utero transfusion and shunting
- Management of complex high risk obstetric cases, ranging from complicated twin pregnancy, fetal growth restriction to maternal acute fatty liver of pregnancy and cardiomyopathy
Education & Qualifications
MBBS (University of London), MRCOG, Cert RCOG (Maternal and Fetal Medicine), MD(Res) (University of London), MSc (Medical Genetics), FHKCOG, FHKAM (Obstetrics and Gynaecology)
Research Interests
- Large-scale multicentre observational studies and randomised controlled trials
- Early prediction and prevention of preeclampsia
- Prediction and prevention of maternal and perinatal morbidity and mortality
- Prediction/detection of aneuploidies, fetal growth restriction, gestational diabetes, macrosomia, stillbirth and spontaneous preterm birth
- Ultrasound in labour and delivery
- Maternal cardiac function
- Prenatal diagnosis and screening
- Multiple pregnancy
Additional Information
Award and Honour
- Visiting Professor, Department of Women and Children’s Health, King’s College London, London, the United Kingdom
- Honorary Member, Hellenic Society of Maternal Fetal Medicine, Greece
Professional Service
- Member, FIGO Committee on Impact of Pregnancy on Long-term Health
- Chairman, Expert Subcommittee on COVID-19 vaccination in pregnancy, The Hong Kong College Of Obstetricians and Gynaecologists
- Founding Board Member, The International Foundation for "Maternal, Periconceptional and Peri-Neonatal Medicine"
- Committee Member, European Association for the Study of the Liver, Clinical Practice Guidelines on Liver Disease and Pregnancy
- Deputy Chairman, Chinese Academy of Maternal Fetal Medicine
- Trustee and Board Member, International Society of Ultrasound in Obstetrics and Gynecology (ISUOG)
- Associate Editor, Maternal-Fetal Medicine
- Editor, Ultrasound in Obstetrics and Gynecology
Academic Engagement in CUHK
- Advisor, Task Force on Women and Family Friendly Policies, The Chinese University of Hong Kong
Selected Publications
Researcher ID: P-9311-2017
- Chaiyasit N, Sahota DS, Ma R, Choolani M, Wataganara T, Sim WS, Chaemsaithong P, Wah YMI, Hui SYA, Poon LC. Prospective Evaluation of International Prediction of Pregnancy Complications Collaborative Network Models for Prediction of Preeclampsia: Role of Serum sFlt-1 at 11-13 Weeks' Gestation. Hypertension 2022; 79:314-322.
- Li X, Milosavljevic A, Elsea SH, Wang CC, Scaglia F, Syngelaki A, Nicolaides KH, Poon LC. Effective Aspirin Treatment of Women at Risk for Preeclampsia Delays the Metabolic Clock of Gestation. Hypertension 2021; 78:1398-1410.
- Yan J, Guo J, Fan C, Juan J, Yu X, Li J, Feng L, Li C, Chen H, Qiao Y, Lei D, Wang C, Xiong G, Xiao F, He W, Pang Q, Hu X, Wang S, Chen D, Zhang Y, Poon LC, Yang H. Coronavirus disease 2019 (COVID-19) in pregnant women: A report based on 116 cases. Am J Obstet Gynecol 2020:S0002-9378(20)30462-2.
- Chaemsaithong P, Sahota D, Pooh RK, Zheng M, Ma R, Chaiyasit N, Koide K, Shaw SW, Seshadri S, Choolani M, Panchalee T, Yapan P, Sim WS, Sekizawa A, Hu Y, Shiozaki A, Saito S, Leung TY, Poon LC. First-trimester pre-eclampsia biomarker profiles in Asian population: a multicenter cohort study. Ultrasound Obstet Gynecol. 2020;56:206-214.
- Chaemsaithong P, Pooh RK, Zheng M, Ma R, Chaiyasit N, Tokunaka M, Shaw SW, Seshadri S, Choolani M, Wataganara T, Yeo GSH, Wright A, Leung WC, Sekizawa A, Hu Y, Naruse K, Saito S, Sahota D, Leung TY, Poon LC. Prospective evaluation of screening performance of first trimester prediction models for preterm preeclampsia in Asian population. Am J Obstet Gynecol. 2019 Dec;221(6):650.e1-650.e16.
- Poon LC, Rolnik DL, Tan MY, Delgado JL, Tsokaki T, Akolekar R, Singh M, Andrade W, Efeturk T, Jani JC, Plasencia W, Papaioannou G, Blazquez AR, Carbone IF, Wright D, Nicolaides KH. ASPRE trial: incidence of preterm preeclampsia in patients fulfilling ACOG and NICE criteria according to risk by the FMF algorithm. Ultrasound Obstet Gynecol 2018;51:738-742.
- Poon LC, Wright D, Rolnik DL, Syngelaki A, Delgado JL, Tsokaki T, Leipold G, Akolekar R, Shearing S, De Stefani L, Jani JC, Plasencia W, Evangelinakis N, Gonzalez-Vanegas O, Persico N, Nicolaides KH. ASPRE trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. Am J Obstet Gynecol. 2017;217:585.e1-585.e5.
- Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tennebaum Gavish K, Meiri H, Gizurarson S, Maclagan K, Nicolaides KH. Aspirin versus Placebo in Pregnancies at High Risk of Preterm Preeclampsia. N Engl J Med 2017;377:613-622.
- O’Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation. Am J Obstet Gynecol 2016; 214:103.e1-103.e12.
- Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009; 53: 812-818.